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1. Introduction
With well-documented ocular complications, diabetes 
mellitus (DM) is a leading cause of blindness throughout the 
world. Although investigations in DM are mostly focused 
on retinal damage, corneal alterations associated with DM 
have also been reported (1–4). Prolonged abnormal glucose 
metabolism results in alterations in the epithelium, stroma, 
and endothelium of the cornea (5). Central corneal thickness 
(CCT), which reflects the metabolic status of the cornea, is 
also influenced by DM (6). These diabetic changes in the 
cornea might have an influence on intraocular pressure 
(IOP) measurements. Therefore, in diabetic patients, accurate 
detection of IOP could be problematic and challenging (7). 
In the current study, we aimed to analyze CCT in type 
II DM patients and to compare the results with age- and 
sex-matched healthy controls. We also investigated the 
association of retinal disease severity and CCT among 
diabetic patients.
2. Materials and methods
The study was done at the Başkent University 
Adana Research and Clinic Center Department of 
Ophthalmology. Patients with type II (noninsulin-
dependent) DM, who were admitted to our outpatient 
clinic, were screened for eligibility for the study. A patient 
who had a referring-physician diagnosis of type II DM 
and who was given antidiabetic medication was defined 
as diabetic. Subjects with a prior history of ocular surgery, 
ocular surface disease, glaucoma, or uveitis and patients 
who had a history of chronic topical medication use were 
not involved in the study. Likewise, past or present contact 
lens wearers were excluded. 
This prospective clinical study was consistent with the 
tenets of the Declaration of Helsinki. Local ethics committee 
approval was obtained. All patients were informed of the 
risks and benefits of the procedure and a written informed 
consent form was obtained from all participants. 
Background/aim: To compare the central corneal thickness (CCT) of type II diabetes mellitus patients with age- and sex-matched 
healthy subjects and to determine the association of the severity of diabetic retinopathy and CCT.
Materials and methods: Type II diabetes mellitus patients without retinopathy, with nonproliferative retinopathy, and with proliferative 
retinopathy were organized as the three subgroups of the study group, and an age- and sex-matched control group was formed. All 
subjects underwent full ophthalmological examination and CCT measurement with ultrasonographic pachymetry. CCT values were 
compared between diabetic and healthy subjects and between the three diabetic subgroups. Correlation analysis was performed to 
determine any relationship between CCT and intraocular pressure.
Results: The average CCT was significantly higher in diabetic patients than in the control group (P = 0.04). CCT in diabetic patients 
without retinopathy did not significantly differ from that of patients with retinopathy (P = 0.64). Similarly, there was no significant 
difference in CCT between nonproliferative and proliferative diabetic retinopathy patients (P = 0.47). In the whole study population, 
CCT was significantly correlated with intraocular pressure (P < 0.01). 
Conclusion: CCT is significantly increased in type II diabetes mellitus patients with respect to controls. Retinal disease severity does not 
seem to have an effect on corneal thickness. 
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Two hundred seventeen eyes of 217 patients were 
enrolled. One eye from each patient was used for analysis. 
Patients with DM were assigned into 3 groups: the first 
group included 59 patients ranging between the ages of 
34 and 75 years (mean: 55 ± 9.8 years) with no diabetic 
retinopathy (DR), the second group included 55 patients 
ranging between the ages of 38 and 78 years (mean: 57.1 
± 8.3 years) with nonproliferative diabetic retinopathy 
(NPDR), and the third group included 51 patients ranging 
between the ages of 41 and 74 years (mean: 56.3 ± 7.2 
years) with proliferative diabetic retinopathy (PDR). The 
control group consisted of 52 age- and sex-matched 
healthy subjects ranging between the ages of 38 and 75 
years (mean: 56.1 ± 7.5 years). The differentiation of 
NPDR and PDR was made as previously reported by the 
Early Treatment Diabetic Retinopathy Study Research 
Group (8).
All patients underwent full ophthalmological 
examination, including thorough biomicroscopic indirect 
fundoscopy through the mydriatic pupil. Intraocular 
pressure was measured by Goldmann’s applanation 
tonometer. Data on age and sex were recorded. Fundus 
fluorescein angiography was performed whenever 
necessary (9). CCT was measured by ultrasonographic 
pachymetry (UP-1000 Ultrasonic Pachymeter, Nidek 
Co., Aichi, Japan) under topical anesthesia. The average 
of 5 consecutive readings was recorded. All pachymetry 
measurements were performed by the same technician 
between 1000 and 1200 hours to eliminate diurnal 
variation in corneal thickness.
For statistical analysis, SPSS 11.0 for Windows (SPSS 
Inc., Chicago, IL, USA) was used. By the Kolmogorov–
Smirnov test, the distribution function of the sample was 
analyzed. In the groups, age, severity of DR, and CCT were 
compared by ANOVA. Different groups were assigned by 
post hoc Tukey HSD test. Independent t-test was used 
to assess the differences among measurements in the 4 
groups and the Pearson correlation coefficient was used 
to investigate the correlation between DM and corneal 
thickness. The level of significance was set at P < 0.05.
3. Results
The male/female ratio of groups 1, 2, and 3 and the 
controls were 23/36, 28/27, 27/24, and 31/21, respectively. 
There was no statistical significance by means of age or sex 
between groups (P = 0.63 and P = 0.34, respectively).
The mean CCT values of each group are given in Table 
1. The average CCT was significantly higher in diabetic 
patients (including all 3 groups) than in the control group 
(P = 0.04). However, CCT in diabetic patients without 
retinopathy did not significantly differ from those of 
patients with retinopathy (P = 0.64). Similarly, there was 
no significant difference in CCT between NPDR and PDR 
patients (P = 0.47).
According to the correlation analysis, in the whole 
cohort, CCT was significantly correlated with IOP (P < 
0.01). These two parameters were significantly correlated 
in both diabetic patients and the controls (r = 0.279, 
P < 0.01 and r = 0.517, P < 0.01, respectively). Table 2 
demonstrates the IOP values of groups. Mean IOP values 
Table 1. Central corneal thickness (µm) values of groups
N (eyes) Mean CCT
95% confidence interval 
Lower bound Upper bound
Group 1 59 552.5 ± 38.0 542.5 562.4
Group 2 55 560.0 ± 32.3 551.3 568.7
Group 3 51 550.1 ± 38.3 539.3 560.8
Controls 52 542.7 ± 31.6 533.9 551.5
Table 2. Intraocular pressure values (mmHg) of groups.
N (eyes) Mean IOP
95% confidence interval
Lower bound Upper bound
Group 1 59 17.1 ± 3.8 16.1 18.1
Group 2 55 16.4 ± 3.3 15.5 17.3
Group 3 51 15.6 ± 4.0 14.5 16.7
Controls 52 15.5 ± 3.4 14.6 16.4
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were higher in diabetic patients than in controls; however, 
the difference was not significant (P = 0.061)
4. Discussion
DM affects the corneal endothelium by altering sodium–
potassium ATPase activity; thus, functional changes occur 
in diabetic corneas (4,10,11). Corneal thickening in both 
type I and II DM was reported in several studies (2,4,12–
15). This increase in corneal thickness reflects the altered 
functional status of the corneal endothelium and may lead 
to falsely high IOP measurements. 
In this current study, we established age- and sex-
matched groups. According to our results, we found 
thicker corneas in type II diabetic patients. Similarly, 
Su et al. found that hyperglycemia was associated with 
increased CCT in their study and explained this finding 
with mechanisms such as corneal endothelial dysfunction, 
stromal hydration, and swelling of the cornea (15). Lee 
et al. reported higher CCT in insulin-dependent DM 
patients compared to controls (4). Roszkowska et al. 
compared diabetic subjects who had background diabetic 
retinopathy with healthy controls and found thicker 
CCT in the diabetic group (2). Ozdamar et al. also found 
thicker central corneas among diabetics with respect to 
nondiabetic controls (14). Recently, Storr-Paulsen et al. 
studied 107 patients with type II DM and 128 nondiabetic 
controls and concluded that CCT was increased among 
type II diabetes patients compared to controls (13). 
In a similar study among type I DM patients, Keoleian 
et al. found that corneal thickness of type I diabetes 
patients did not significantly differ from the age-matched 
nondiabetic control subjects. However, they found altered 
morphology of the endothelium among diabetics (16). 
Likewise, Inoue et al. and Wiemer et al. did not report any 
differences in CCT between diabetics and controls (17,18). 
In the current study, no significant difference was found 
in CCT between the three diabetic subgroups. Busted et al. 
and Wiemer et al. also found that CCT increased in DM 
regardless of the severity of the retinal disease (12,18). 
Ozdamar et al. reported in their study that patients with 
proliferative retinopathy had thicker CCT than those with 
nonproliferative retinopathy and no retinopathy; however, 
the difference was not statistically significant (14). 
Other than corneal hydration and swelling, the 
increase in CCT may also be a result of increased collagen 
crosslinking due to the accumulation of advanced 
glycosylation end products, a process related both to 
diabetes and normal aging. Collagen crosslinking may 
lead to corneal thickening and gradual stiffening of the 
cornea and consequently affect the accuracy of IOP 
measurements (19). The influence of CCT and corneal 
biomechanics on IOP measurement was shown in a study 
by Broman et al. (20).
In the current study, CCT was found to be significantly 
correlated with IOP, as expected. Average IOP values of the 
diabetic subjects were also higher than those of the healthy 
controls; however, this difference was not statistically 
significant. Results of studies with large series have shown 
that DM is associated with high IOP measurements (21,22). 
Both increased CCT and increased corneal stiffness due to 
collagen crosslinking cause overestimation of the IOP in 
diabetic patients; therefore, diabetes may have a preventive 
effect on glaucoma progression (5,7). Nevertheless, we 
think that diabetic patients must be closely followed 
for IOP rise or glaucoma progression, because, in daily 
practice, IOP readings might sometimes be overlooked, as 
the physician usually focuses on retinopathy. 
In conclusion, we found increased CCT in type II 
DM regardless of the severity of the retinal disease. This 
increase in CCT was correlated with IOP. In our opinion, 
increased corneal thickness should be kept in mind when 
measuring and evaluating IOP in diabetic patients. It 
should be investigated in further studies whether corneal 
thickness could be an indicator of the metabolic status of 
DM.
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